Drug combination shows promise against cancer's 'death star' protein
A drug combination targeting multiple mutant versions of cancer's "death star" protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.
Jun 6, 2022
0
541